Actinium Pharmaceuticals (ATNM)
Develops targeted radiotherapies for cancer and transplant conditioning.
$1.20
vs last close+0.03 (+2.56%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 51 days
EPS estimate
−$0.25
Revenue estimate
$1.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.21−$0.51−$0.22−$0.16−$0.19−$0.18$0.89Pending
Estimate−$0.37−$0.26−$0.32−$0.25−$0.19−$0.22−$0.20−$0.25
Surprise+43.2%−96.2%+31.3%+36.0%−1.8%+18.2%+545.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$810.0K——$90.0K——$35.0MPending
Estimate———$67.5K$600.0K$2.5M$35.0M$1.2M
Surprise———+33.3%——0.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.08 | — | — |
| Sep 2027 | −$0.08 | — | — |
| Jun 2027 | −$0.08 | — | — |
| Mar 2027 | −$0.09 | — | — |
| Dec 2026 | −$0.23 | — | — |
| Nov 2026 | −$0.25 | — | — |
| Aug 2026 | −$0.20 | $0.89 | +545.0% |
| May 2026 | −$0.22 | −$0.18 | +18.2% |
| Mar 2026 | −$0.19 | −$0.19 | −1.8% |
| Nov 2025 | −$0.25 | −$0.16 | +36.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| May 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Oct 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.08 | — | — | $12.2M | — | — | — |
| Sep 2027 | −$0.08 | — | — | $14.5M | — | — | — |
| Jun 2027 | −$0.08 | — | — | $17.3M | — | — | — |
| Mar 2027 | −$0.09 | — | — | $20.6M | — | — | — |
| Dec 2026 | −$0.23 | — | — | $1.9M | — | — | — |
| Nov 13, 2026 | −$0.25 | — | — | $1.2M | — | — | — |
| Aug 7, 2026 | −$0.20 | $0.89 | +545.0% | $35.0M | $35.0M | 0.0% | +1.3% |
| May 8, 2026 | −$0.22 | −$0.18 | +18.2% | $2.5M | — | — | +2.3% |
| Mar 30, 2026 | −$0.19 | −$0.19 | −1.8% | $600.0K | — | — | +0.5% |
| Nov 14, 2025 | −$0.25 | −$0.16 | +36.0% | $67.5K | $90.0K | +33.3% | +1.6% |
| Aug 8, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 5, 2024 | |||||||
| Apr 26, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Apr 3, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 25, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Jul 30, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Oct 23, 2020 | |||||||
| Aug 14, 2020 | |||||||
| Jun 30, 2020 | |||||||
| May 8, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 19, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 16, 2018 | |||||||
| Nov 3, 2017 | |||||||
| Aug 4, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Oct 28, 2016 | |||||||
| Jul 29, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Oct 30, 2015 | |||||||
| Aug 7, 2015 |